Nabumetone


CAS No. : 42924-53-8

(Synonyms: BRL14777)

42924-53-8
Price and Availability of CAS No. : 42924-53-8
Size Price Stock
1g $33 In-stock
5g $73 In-stock
25g $245 In-stock
50 g Get quote
100 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-B0559
M.Wt: 228.29
Formula: C15H16O2
Purity: >98 %
Solubility: DMSO : ≥ 100 mg/mL;H2O : < 0.1 mg/mL
Introduction of 42924-53-8 :

Nabumetone is an orally active non-acidic anti-inflammatory agent, acts as a potent and selective COX-2 inhibitor, and is the proagent of the active metaboliteα-Demethylnaproxen (HY-W086896). Nabumetone can inhibit cancer cells proliferation and relieve gastric ulcers[1][2][3]. IC50 & Target:COX-2[1] In Vitro:Nabumetone (50-500 μM, 48 h) dose-dependently inhibits the proliferation of K-562 and Meg-01 cells, but shows no obvious apoptotic effect[1].
Nabumetone (50-100 μM) potentiates the apoptotic effect of ADR (HY-15142) and reduces Bcl-2 expression in the K-562 cells[1].
In Vivo:Nabumetone (79 mg/kg, p.o.) inhibits paw oedema and paw exudate PGE in rats[2].
Nabumetone does not induce gastric damage and causes only 57% inhibition of gastric mucosal 6-keto-PGF production in rats[2].
Nabumetone (25, 50, 100 mg/kg, i.p.) dose-dependently inhibits the increase of Diethyldithiocarbamate-induced mucus secretion and stimulates stress-induced mucus secretion in rats[3].
Nabumetone (25 mg/kg, i.p.) significantly suppresses stress-induced ulcer index in rats[3].

Your information is safe with us.